TILRAY MEDICAL Logo (WIPO, 05/31/2022)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark TILRAY MEDICAL was filed as Figurative mark on 05/31/2022 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Different geometrical figures, juxtaposed, joined or intersecting #Letters presenting a special form of writing #Triangles or lines forming an angle with one or more polygons other than quadrilaterals #Series of letters in different dimensions
| Trademark form | Figurative mark |
| File reference | 1685348 |
| Countries | 
|
| Base trademark |
No. 2151532,
December 2, 2021
|
| Application date | May 31, 2022 |
| Expiration date | May 31, 2032 |
Trademark owner
655 Madison Ave., 19th Floor
New York NY 10065
US
New York NY 10065
US
Trademark representatives
333 Bay Street, Suite 2400,
Bay Adelaide Centre, Box 20
CA
goods and services
05
Cannabis related products, namely oils, salves, concentrated
pastes, tinctures, tablets and capsules, each containing
cannabis for medicinal purposes for the relief of pain, for
relaxation, for reducing stress and fatigue, for mood
enhancement, for maintaining general health and well-being,
for relieving anxiety, for relieving depression, as a sleep
aid and for management of opioid addiction and relief of
epilepsy; oils, salves, concentrated pastes, tinctures,
tablets and capsules each containing resins and oils derived
from cannabis for medicinal purposes for the relief of pain,
for relaxation, for reducing stress and fatigue, for mood
enhancement, for maintaining general health and well-being,
for relieving anxiety, for relieving depression, as a sleep
aid and for management of opioid addiction and relief of
epilepsy; nutraceuticals for medicinal purposes for the
relief of pain, for relaxation, for reducing stress and
fatigue, for mood enhancement, for maintaining general
health and well-being, for relieving anxiety, for relieving
depression, as a sleep aid and for management of opioid
addiction and relief of epilepsy; nutraceuticals for
medicinal purposes containing cannabis for the relief of
pain, for relaxation, for reducing stress and fatigue, for
mood enhancement, for maintaining general health and
well-being, for relieving anxiety, for relieving depression,
as a sleep aid and for management of opioid addiction and
relief of epilepsy; nutraceuticals for medicinal purposes
containing derivatives of cannabis, namely resins and oils
for the relief of pain, for relaxation, for reducing stress
and fatigue, for mood enhancement, for maintaining general
health and well-being, for relieving anxiety, for relieving
depression, as a sleep aid and for management of opioid
addiction and relief of epilepsy; topical skin creams, bar
and liquid soaps, bath additives, bath herbs, bath oils,
body creams, body oils, face and body lotions, face and body
milk, face lotion, and skin care preparations each
containing derivatives of cannabis, for the relief of pain,
for relaxation, for reducing stress and fatigue, for mood
enhancement, for maintaining general health and well-being,
for relieving anxiety, for relieving depression, as a sleep
aid and for management of opioid addiction and relief of
epilepsy; personal sexual lubricants; transdermal patches
containing cannabis for the relief of pain, for relaxation,
for reducing stress and fatigue, for mood enhancement, for
maintaining general health and well-being, for relieving
anxiety, for relieving depression, as a sleep aid and for
management of opioid addiction and relief of epilepsy; oral
sprays containing cannabis for medicinal use for the relief
of pain, for relaxation, for reducing stress and fatigue,
for mood enhancement, for maintaining general health and
well-being, for relieving anxiety, for relieving depression,
as a sleep aid and for management of opioid addiction and
relief of epilepsy; cannabis and marijuana for medicinal
purposes for the relief of pain, for relaxation, for
reducing stress and fatigue, for mood enhancement, for
maintaining general health and well-being, for relieving
anxiety, for relieving depression, as a sleep aid and for
management of opioid addiction and relief of epilepsy;
cannabis related product, namely, oils for medicinal use for
the relief of pain, for relaxation, for reducing stress and
fatigue, for mood enhancement, for maintaining general
health and well-being, for relieving anxiety, for relieving
depression, as a sleep aid and for management of opioid
addiction and relief of epilepsy; oils derived from cannabis
for medicinal use for the relief of pain, for relaxation,
for reducing stress and fatigue, for mood enhancement, for
maintaining general health and well-being, for relieving
anxiety, for relieving depression, as a sleep aid and for
management of opioid addiction and relief of epilepsy
31
Live cannabis plants; live marijuana plants; cannabis seeds
for agricultural purposes
41
Providing entertainment information in the field of cannabis
culture via a website; providing news via a website in the
nature of current event reporting in the field of cannabis
and cannabis culture; providing educational information in
the field of cannabis via a website
42
Research services in the area of marijuana and cannabis,
cannabis related products, derivatives of cannabis, and
natural health products containing cannabis
44
Providing the breeding, growing, cultivation, and harvesting
of marijuana and cannabis; production of marijuana and
cannabis, namely, cultivation of marijuana and cannabis
plants
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 8, 2023 | 2023/32 Gaz | CH | Rejection |
| July 15, 2023 | 2023/29 Gaz | CO | Rejection |
| July 10, 2023 | 2023/28 Gaz | PT | Rejection |
| June 21, 2023 | 2023/28 Gaz | BR | Rejection |
| May 2, 2023 | 2023/18 Gaz | IL | Rejection |
| April 14, 2023 | 2023/16 Gaz | DK | Rejection |
| March 14, 2023 | 2023/12 Gaz | FR | Rejection |
| February 28, 2023 | 2023/9 Gaz | NZ | Rejection |
| February 27, 2023 | 2023/9 Gaz | CN | Rejection |
| February 23, 2023 | 2023/8 Gaz | DE | Rejection |
| February 13, 2023 | 2023/7 Gaz | EM | Rejection |
| February 6, 2023 | 2023/6 Gaz | BX | Rejection |
| January 31, 2023 | 2023/6 Gaz | PL | Rejection |
| December 21, 2022 | 2022/51 Gaz | GB | Rejection |
| October 11, 2022 | 2022/41 Gaz | AU | Rejection |
| May 31, 2022 | 2022/36 Gaz | CA | Registration |
ID: 141685348